Multidrug resistance in lung cancer
- 1 January 1994
- book chapter
- Published by Springer Nature
- Vol. 72, 193-222
- https://doi.org/10.1007/978-1-4615-2630-8_10
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- In vitro prediction of cytostatic drug resistance in primary cell cultures of solid malignant tumoursEuropean Journal Of Cancer, 1993
- Chemosensitisation and drug accumulation effects of cyclosporin A, PSC-833 and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoproteinEuropean Journal Of Cancer, 1993
- Some monoclonal antibody reagents (C219 and JSB-1) to P-glycoprotein contain antibodies to blood group A carbohydrate determinants: a problem of quality control for immunohistochemical analysis.Journal of Histochemistry & Cytochemistry, 1991
- Addition of verapamil and tamoxifen to the initial chemotherapy of small cell lung cancer a phase I/II studyCancer, 1990
- Multidrug resistance and its circumventionEuropean Journal of Cancer and Clinical Oncology, 1990
- Overexpression of P-glycoprotein in Mammalian Tumor Cell Lines After Fractionated X Irradiation In VitroJNCI Journal of the National Cancer Institute, 1990
- Quantitative Determination of Factors Contributing to Doxorubicin Resistance in Multidrug-Resistant CellsJNCI Journal of the National Cancer Institute, 1989
- Nonproductive Rearrangement of DNA Topoisomerase I and II Genes: Correlation With Resistance to Topoisomerase InhibitorsJNCI Journal of the National Cancer Institute, 1989
- In vitro chemosensitivity of human lung cancer for vindesineEuropean Journal of Cancer and Clinical Oncology, 1987